Gynecologic Cancer

Women with early cervical cancer who conceived at least 3 months after fertility-sparing surgery had a high live birth rate, according to results presented at the virtual Society of Gynecologic Oncology Annual Meeting on Women’s Cancer.

Olaparib maintenance significantly extended 5-year PFS for women with advanced BRCA-positive ovarian cancer, according to results presented at the virtual Society of Gynecologic Oncology Annual Meeting on Women’s Cancer.

Chemotherapy did not increase risk for hospitalization or death due to COVID-19 among women with gynecologic cancer, according to results presented at the virtual Society of Gynecologic Oncology Annual Meeting on Women’s Cancer.

Minimally invasive interval debulking surgery may benefit women with advanced epithelial ovarian cancer who received neoadjuvant chemotherapy, findings presented at Society of Gynecologic Oncology Annual Meeting on Women’s Cancer showed.

Lenvatinib plus pembrolizumab improved outcomes vs. chemotherapy for women with advanced endometrial cancer, according to findings presented at the virtual Society of Gynecologic Oncology Annual Meeting on Women’s Cancer.

Leslie R. Boyd, MD, has been appointed director of the division of gynecologic oncology at Laura and Isaac Perlmutter Cancer Center at NYU Langone Health.

High daily dietary cadmium intake appeared associated with shorter OS among women with endometrial cancer, according to study results published in Nutrition and Cancer.

Amid the COVID-19 pandemic, people are putting off care, letting self-care strategies slip and falling back into unhealthy habits as they spend more time isolated and at home.

The FDA granted priority review to pafolacianine sodium injection as an intraoperative adjunct to help identify ovarian cancer during surgery, according to the agent’s manufacturer.

The FDA granted fast track designation to GEN-1 for treatment of advanced ovarian cancer, according to the agent’s manufacturer.